InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,352.96
(
-0.02%
)
US TECH 100
18,534.80
(
0.00%
)
Dow Jones
38,886.17
(
0.20%
)
Brent Oil
79.70
(
-0.23%
)
Bitcoin
71,193.97
(
0.61%
)
Post# of 44226
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Gonzal

Send PM Follow Ignore
Followers 3
Posts 575
Boards Moderated 0
Alias Born 08/27/2020

Gonzal

Re: None

Thursday, 09/01/2022 2:16:47 PM

Thursday, September 01, 2022 2:16:47 PM

Post# of 44226
IMO it’s pursuing Metformin Eye Drop 1st

Total cost estimates are $30 million to achieve inflection points, I think Metformin eye drop will be leverage to achieve their goals
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CUBT News
More CUBT News
InvestorsHub NewsWire

Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM

Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM

Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM

Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM

IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM

ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM

Start posting your company's news
Only $200 per official company press release!